患者参与影响研究核心结局集的结果域选择:一项更新的系统评价
该更新系统评价纳入2020年发表的56项和2021年发表的54项核心结局集(COS)研究,评估患者参与对COS的影响。有患者或其代表参与的COS更可能纳入生活影响结局(239,86%),而无患者参与的COS为(193,62%)。作者鼓励COS制定者更关注共识过程的方法与报告。
要点
- 有患者参与的COS纳入生活影响结局的比例为86%(239项),无患者参与为62%(193项)。
- 2020年研究中42项(75%)、2021年研究中45项(83%)满足利益相关方全部三项标准。
- 仅19项(34%)2020年研究和18项(33%)2021年研究满足共识过程全部四项标准。
核心结论
- 有患者或其代表参与的COS更可能纳入生活影响结局(239,86%),而无患者参与的COS为(193,62%)。
- 作者鼓励COS制定者更加关注与共识过程相关的方法和报告。
- 需要进一步研究以理解结局域之间粒度水平差异的适当性和理由。
研究设计与样本
- 采用既往更新中使用的系统评价方法,分别检索2020年和2021年发表或索引的COS制定研究,不限条件、人群、干预或场景。
- 共识别2020年发表的56项新研究和2021年发表的54项新研究。
- 依据已发表的COS制定标准评估研究,并按结局分类法提取核心结局,纳入既往所有已发表COS的核心结局分类数据库。
- 分析患者参与对核心结局域的影响。
主要发现
- 所有研究均满足范围相关的全部四项最低标准。
- 2020年研究中42项(75%)、2021年研究中45项(83%)满足利益相关方参与的全部三项标准。
- 仅19项(34%)2020年研究和18项(33%)2021年研究满足共识过程的全部四项标准。
- 有患者或其代表参与的COS更可能纳入生活影响结局(239,86%),而无患者参与的COS为(193,62%)。
- 生理/临床结局几乎总是以细化粒度指定,而生活影响结局常以较高层级描述。
临床怎么用
- 作者鼓励COS制定者更加关注与共识过程相关的方法和报告。
- 需要进一步研究以理解结局域之间粒度水平差异的适当性和理由。
局限性
- 需要进一步研究以理解结局域之间粒度水平差异的适当性和理由。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The importance of including patients, carers, and the public in health research is well recognized, including the need to consider outcomes in health care research that reflect the priorities of patients. Core outcome sets (COS) define the minimum set of outcomes that should be measured and reported in research of a given condition, determined through consensus among key stakeholders. The Core Outcome Measures in Effectiveness Trials Initiative undertakes an annual systematic review (SR) to identify newly published COS to update its online database of COS for research. The objective of this study was to assess the impact of patient participation on COS. STUDY DESIGN AND SETTING: SR methods used in previous updates were applied to identify research studies published or indexed in 2020 and 2021 (conducted as separate reviews) that report development of a COS, regardless of any specifications relating to condition, population, intervention, or setting. Studies were assessed according to published standards for COS development, and core outcomes extracted from study publications were categorized according to an outcome taxonomy and added to an existing database of core outcome classifications of all previously published COS. The effect of patient participation on core domains was examined. RESULTS: Searches identified 56 new studies published in 2020 and 54 in 2021. All studies met all four minimum standards for scope, and 42 (75%) of the 2020 studies and 45 (83%) of the 2021 studies met all three standards for stakeholders involved. However, only 19 (34%) of the 2020 studies and 18 (33%) of the 2021 studies met all four standards for the consensus process. COS that involved patients or their representatives are more likely to include life impact outcomes (239, 86%) than COS without patient participation (193, 62%). Physiological/clinical outcomes are almost always specified at a granular level, whereas life impact outcomes are often described at a higher level. CONCLUSION: This study adds to the body of evidence demonstrating the importance and impact of including patients, carers, and the public in COS development, in particular by demonstrating that the impact of interventions on patients' lives is more likely to be represented in COS that involve patients or their representatives. COS developers are encouraged to pay increased attention to methods and reporting relating to the consensus process. Further work is required to understand the appropriateness and rationale for the discrepancy in granularity levels between outcome domains.
引用
- Dodd S, Gorst SL, Young A, et al. Patient participation impacts outcome domain selection in core outcome sets for research: an updated systematic review. J Clin Epidemiol. 2023. PMID: 37054902. doi:10.1016/j.jclinepi.2023.03.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。